Technical note – Biomolecular labelling strategies for smFRET

Format

Technical note

To perform a single-molecule Förster Resonance Energy Transfer (smFRET) experiment, biomolecules of interest must be labelled with a dye pair that can undergo FRET. The choice of dyes and their placement has a profound impact on the resultant data and therefore must be considered carefully when designing smFRET experiments.

The technical note will guide you through these practical considerations and provide recommended protocols to help you prepare for your own smFRET experiments.

Overview of this technical note:

  • Discussion of various commercially available dye pairs and ideal characteristics for FRET
  • Methods for site-specific labelling for proteins and nucleic acids
  • Important considerations that influence how a dye pair may behave in different biomolecular environments or distances from one another
Graph depicting the excitation and emission spectra for Cy3 and Cy5, indicating spectral overlap.

Figure 1 – Excitation and emission spectra for Cy3 and Cy5 fluorophores

Excitation spectra are indicated by dashed lines; emission spectra are indicated by solid lines. Hashed areas show overlap between Cy3 emission and Cy5 excitation wavelengths, where FRET can occur.

Note – spectra are illustrative, not exact.

Recent posts

Discover how fluorescence cross-correlation spectroscopy (FCCS) can simplify ternary complex analysis in drug discovery. This practical handbook explores in-solution measurement of complex formation, hook effects, cooperativity and stability, with real-world workflows for targeted protein degradation and multi-specific biologics.
In this press release, we announce the launch of the PhotonFit analysis software, a streamlined software platform designed to remove long-standing technical barriers to smFRET, FCS, and FCCS data processing.
Discover how solution-phase single-molecule techniques (smFRET, FCS, FCCS) bridge structural biology with kinetic mechanisms across nutrient sensing, viral replication, and therapeutic antibody targeting.